Population pharmacokinetic-pharmacodynamic analysis of anidulafungin in adult patients with fungal infections.
about
Population pharmacokinetic analysis of voriconazole and anidulafungin in adult patients with invasive aspergillosis.Pharmacokinetics of anidulafungin in critically ill patients with candidemia/invasive candidiasisDoes Weight Impact Anidulafungin Pharmacokinetics?Pharmacokinetics of Anidulafungin in Critically Ill Intensive Care Unit Patients with Suspected or Proven Invasive Fungal InfectionsA rationale for reduced-frequency dosing of anidulafungin for antifungal prophylaxis in immunocompromised patients.Impact of special patient populations on the pharmacokinetics of echinocandins.Dosing of antifungal agents in obese people.Pharmacokinetic study of anidulafungin in ICU patients with intra-abdominal candidiasis.Dose optimization of voriconazole/anidulafungin combination against Aspergillus fumigatus using an in vitro pharmacokinetic/pharmacodynamic model and response surface analysis: clinical implications for azole-resistant aspergillosis.Azole-resistant Candida albicans prosthetic joint infection treated with prolonged administration of anidulafungin and two-stage exchange with implant of a mega-prosthesis.
P2860
Q34058346-B6A0F654-BC01-41B3-BF21-B570796956ABQ36757660-27C04087-19CA-46DC-8D6B-F17B25846595Q37253669-D5992981-47C6-4D2F-8182-D715F9B00013Q37612946-40CD5759-6113-41BC-8954-E8DFAF18BEDCQ38419657-A3B779D3-5548-4C10-8E8C-1A964935C4C0Q38462784-49F6F681-0273-4746-8CB8-946FAAF5BA78Q38660761-A6D8EC04-FCCB-4FB6-99AF-966C5CDA9999Q39020129-4D822189-BC87-4BF3-AD6A-F7F4C7944FB1Q40587101-B1BCDD14-5AE2-471E-B9FA-F67F7A46CBE8Q40606434-9E9DB23A-BABB-46C7-BEA0-DD7EB817C0A4
P2860
Population pharmacokinetic-pharmacodynamic analysis of anidulafungin in adult patients with fungal infections.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Population pharmacokinetic-pha ...... tients with fungal infections.
@ast
Population pharmacokinetic-pha ...... tients with fungal infections.
@en
type
label
Population pharmacokinetic-pha ...... tients with fungal infections.
@ast
Population pharmacokinetic-pha ...... tients with fungal infections.
@en
prefLabel
Population pharmacokinetic-pha ...... tients with fungal infections.
@ast
Population pharmacokinetic-pha ...... tients with fungal infections.
@en
P2860
P356
P1476
Population pharmacokinetic-pha ...... tients with fungal infections.
@en
P2093
P2860
P304
P356
10.1128/AAC.01473-12
P407
P577
2012-11-05T00:00:00Z